Literature DB >> 12244556

Neuroimaging fails to identify asymptomatic carriers of familial porencephaly.

C Vilain1, N Van Regemorter, A Verloes, P David, P Van Bogaert.   

Abstract

Familial porencephaly is a rare condition usually transmitted as an autosomal dominant trait with incomplete penetrance. We describe a new family in which six members across four generations had congenital hemiplegia. Cerebral imaging was performed in three patients and showed porencephaly in all cases. In order to provide effective genetic counseling, three asymptomatic carriers were investigated by cerebral computerized tomography (three patients) and cerebral magnetic resonance imaging (one patient). These investigations failed to show any congenital abnormalities. We conclude that cerebral imaging is unreliable to detect obligate carriers of familial porencephaly. Copyright 2002 Wiley-Liss, Inc.

Entities:  

Mesh:

Year:  2002        PMID: 12244556     DOI: 10.1002/ajmg.10452

Source DB:  PubMed          Journal:  Am J Med Genet        ISSN: 0148-7299


  6 in total

1.  'De novo' Col4A2 mutation in a patient with migraine, leukoencephalopathy, and small carotid aneurysms.

Authors:  Paul Kollmann; André Peeters; Olivier Vanakker; Yves Sznajer
Journal:  J Neurol       Date:  2016-09-13       Impact factor: 4.849

2.  De novo and inherited mutations in COL4A2, encoding the type IV collagen α2 chain cause porencephaly.

Authors:  Yuriko Yoneda; Kazuhiro Haginoya; Hiroshi Arai; Shigeo Yamaoka; Yoshinori Tsurusaki; Hiroshi Doi; Noriko Miyake; Kenji Yokochi; Hitoshi Osaka; Mitsuhiro Kato; Naomichi Matsumoto; Hirotomo Saitsu
Journal:  Am J Hum Genet       Date:  2011-12-29       Impact factor: 11.025

Review 3.  Genotype-phenotype correlations in pathology caused by collagen type IV alpha 1 and 2 mutations.

Authors:  Marion Jeanne; Douglas B Gould
Journal:  Matrix Biol       Date:  2016-10-26       Impact factor: 11.583

4.  Novel mutations in three families confirm a major role of COL4A1 in hereditary porencephaly.

Authors:  G Breedveld; I F de Coo; M H Lequin; W F M Arts; P Heutink; D B Gould; S W M John; B Oostra; G M S Mancini
Journal:  J Med Genet       Date:  2005-08-17       Impact factor: 6.318

5.  Chemical chaperone treatment reduces intracellular accumulation of mutant collagen IV and ameliorates the cellular phenotype of a COL4A2 mutation that causes haemorrhagic stroke.

Authors:  Lydia S Murray; Yinhui Lu; Aislynn Taggart; Nicole Van Regemorter; Catheline Vilain; Marc Abramowicz; Karl E Kadler; Tom Van Agtmael
Journal:  Hum Mol Genet       Date:  2013-09-02       Impact factor: 6.150

6.  Identification of fibronectin 1 as a candidate genetic modifier in a Col4a1 mutant mouse model of Gould syndrome.

Authors:  Mao Mao; Tanav Popli; Marion Jeanne; Kendall Hoff; Saunak Sen; Douglas B Gould
Journal:  Dis Model Mech       Date:  2021-04-26       Impact factor: 5.758

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.